Value and Perspectives of Proton Radiation Therapy for Limited Stage Prostate Cancer

被引：0
|
作者：
Reinhard W. Schulte
Jerry D. Slater
Carl J. Rossi Jr.
James M. Slater
机构：
[1] Department of Radiation Medicine,
[2] Loma Linda University Medical Center (LLUMC),undefined
[3] USA,undefined
来源：
Strahlentherapie und Onkologie | 2000年 / 176卷
关键词：
Key Words: Proton beam irradiation; Prostate cancer; Toxicity; Schlüsselwörter: Protonenbestrahlung; Prostatakarzinom; Toxizität;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This review article will focus on clinical results and limitations of proton beam irradiation. Possible technological, biological and medical perspectives will be addressed.
引用
收藏
页码：3 / 8
页数：5
相关论文
共 50 条
  • [41] Dose-volume comparison of proton therapy and intensity modulated radiation therapy in the treatment of prostate cancer
    Vargas, C. E.
    Fryer, A.
    Mahajan, C.
    Indelicato, D.
    Horne, D.
    Chellini, A.
    McKenzie, C.
    Lawlorl, P.
    Li, Z.
    Keole, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S338 - S339
  • [42] Proton Radiation Therapy for Prostate Cancer in the Medicare Population: Patterns of Care and Comparison of Early Toxicity With Intensity Modulated Radiation Therapy
    Yu, J. B.
    Soulos, P. R.
    Herrin, J.
    Cramer, L. D.
    Potosky, A. L.
    Roberts, K. B.
    Gross, C. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S13 - S13
  • [43] Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives
    Serrano, Nicholas A.
    Kalman, Noah S.
    Anscher, Mitchell S.
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 339 - 350
  • [44] Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancer
    Latorzeff, I.
    Camps-malea, A.
    Supiot, S.
    De Crevoisier, R.
    Farcy-jacquet, M. -P.
    Hannoun-levi, J. -M.
    Riou, O.
    Pommier, P.
    Artignan, X.
    Chapet, O.
    Crehange, G.
    Marchesi, V.
    Pasquier, D.
    Sargos, P.
    CANCER RADIOTHERAPIE, 2024, 28 (01): : 49 - 55
  • [45] Value of lymphadenectomy for limited nodal recurrence of prostate cancer after local therapy with curative intent
    Wolff, I.
    Grimm, M. -O.
    Wirth, M.
    UROLOGE, 2008, 47 (11): : 1436 - 1440
  • [46] The value of biphosphonates in the therapy of prostate cancer
    Rolfes, N.
    Luemmen, G.
    UROLOGE, 2009, 48 (09): : 990 - +
  • [47] Value of targeted therapy for prostate cancer
    Boergermann, C.
    vom Dorp, F.
    Schenck, M.
    Becker, M.
    Hess, J.
    Ruebben, H.
    UROLOGE, 2008, 47 (10): : 1315 - +
  • [48] Clinical Controversies: Proton Therapy for Prostate Cancer
    Mouw, Kent W.
    Trofimov, Alexei
    Zietman, Anthony L.
    Efstathiou, Jason A.
    SEMINARS IN RADIATION ONCOLOGY, 2013, 23 (02) : 109 - 114
  • [49] Curative radiation therapy in prostate cancer
    Harmenberg, Ulrika
    Hamdy, Freddie C.
    Widmark, Anders
    Lennernas, Bo
    Nilsson, Sten
    ACTA ONCOLOGICA, 2011, 50 : 98 - 103
  • [50] Postprostatectomy radiation therapy for prostate cancer
    Abramowitz, Matthew C.
    Pollack, Alan
    SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (01) : 15 - 22
12345